Your cells depend on the SETBP1 gene to help control when other genes are switched on or off, especially during early brain development. If this gene does not work properly, development can be affected, often leading to delayed speech and learning, and sometimes seizures, behavior differences, or growth problems. Some variants make the gene overactive and are linked to Schinzel Giedion syndrome, while variants that reduce its activity can cause a different developmental condition linked to the SETBP1 gene.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or manage activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do the work. Others are involved mainly in regulating when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence your response to food, stress, and medicines. For a deeper look at this subject, more information is available in the LearnHub.
Overview
SETBP1Gene function
What if the gene works
The SETBP1 gene helps control how other genes are switched on and off. It is especially important during brain development and supports learning and speech.
Risk
What if the gene does not work
Variants in the SETBP1 gene are linked to changes in brain development, often causing speech and language problems, learning difficulties, or intellectual disability. More disruptive variants may cause a much earlier and broader syndrome with growth, feeding, and seizure problems.
Treatment
What does that mean for your treatment
No treatment or drug choice specific to pathogenic or loss-of-function variants in the SETBP1 gene is currently established in clinical guidelines. The SETBP1 gene is being studied mainly as a cancer biomarker and possible drug target, especially in some leukemias.
Conditions associated with SETBP1
Gene function
What if the gene works
In early development, your cells use the SETBP1 gene to help control which instructions are read and when. This matters in growing tissues, especially the brain, where careful timing helps cells divide, mature, and take on the right roles. Understanding how the SETBP1 gene works in early brain development helps show why organized gene control matters for the body.
The SETBP1 gene helps manage when other genes are switched on or off. Its protein attaches to DNA control areas and works with partner proteins so cells can follow the right program.
The SETBP1 protein works with other proteins involved in gene control, including the SET protein. These partnerships help coordinate normal growth and development inside cells.
This gene supports the timing of cell growth and division during development. By helping cells read the right instructions at the right moment, it supports orderly tissue building.
During early life, the SETBP1 gene is active in the developing nervous system. It helps guide gene activity that supports the formation and maturation of brain cells.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help explain normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not produce any noticeable effect and are part of natural genetic variation. In certain cases, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How SETBP1 gene variants affect the protein depends on the change. Some variants reduce or truncate the SETBP1 protein, leaving less working protein in cells, while certain missense variants make it unusually stable so it is not broken down on time and can build up. This spectrum from milder loss of function to stronger gain of function often shapes whether features are more limited or appear earlier and are more pronounced, as in Schinzel-Giedion syndrome.
How variants are linked to conditions
Pathogenic variants in the SETBP1 gene are mainly linked to two rare neurodevelopmental conditions. Certain variants can cause Schinzel-Giedion syndrome, while other variants cause SETBP1 haploinsufficiency disorder, which is often associated with speech delay, developmental delay, and intellectual disability. Inherited SETBP1 gene variants linked to conditions are different from acquired SETBP1 variants that are associated with some myeloid blood cancers.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widely seen in the general population. Most do not directly affect health and simply contribute to normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than establishing a diagnosis, particularly when several genes and environmental influences play a role. Still, in certain situations, one well-defined variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence that lifestyle or environmental factors change health risks linked to the SETBP1 gene. For many living with a SETBP1-related condition, risk is mainly shaped by the specific gene change itself and whether it was inherited or happened for the first time in the family.
Inheritance of SETBP1 variants
For SETBP1-related conditions, how variants of the SETBP1 gene are inherited is usually described as autosomal dominant. This means a variant in one copy of the SETBP1 gene can be enough to cause the condition, and an affected parent has a 50% chance in each pregnancy of passing it to a child. Many cases, especially Schinzel-Giedion syndrome, happen because of a new de novo variant that was not inherited from either parent.
What does my SETBP1 result mean for my family?
For SETBP1, the best-known related conditions usually follow a dominant pattern, which means a parent with the variant can pass it to a child, and close relatives may also carry it. Many living with a SETBP1-related condition have a new gene change that was not inherited from either parent, so a parent is not always the source. Because of this, what it means for family members can vary, but parents, brothers, sisters, and children are often the relatives most considered.
Genetic information
Genetic testing
How you find out about variants
To find a variant in the SETBP1 gene, clinicians use genetic testing for SETBP1 variants on a blood sample, saliva sample, or cheek swab. A lab reads the gene’s DNA code and looks for changes, then compares any variant with established medical evidence to see whether it may help explain symptoms or support a diagnosis.
When should I consider getting a genetic test?
A genetic test may be worth considering when a child has unexplained developmental delay, very limited speech, low muscle tone, seizures, or other signs of a condition linked to changes in the SETBP1 gene, especially when similar concerns run in the family. Results can help explain the cause and guide care.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This is a common reason why the same treatment may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the SETBP1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication decisions. Questions about medicines, side effects, or treatment changes are best discussed with your doctor or pharmacist.
History
Schinzel-Giedion syndrome was recognized from its clinical features years before the underlying cause was known. In 2010, researchers linked de novo, or new, variants in the SETBP1 gene to this condition, giving families and clinicians a clearer genetic explanation. From these first observations, research expanded steadily. Soon after, acquired variants in the SETBP1 gene were identified in several blood cancers, especially atypical chronic myeloid leukemia, which raised wider scientific interest. Later studies showed that losing one working copy of the SETBP1 gene can also be tied to speech and language difficulties and developmental differences. Over time, this history turned SETBP1 from a little-known gene into an important part of rare disease and cancer genetics.